MK-677 (Ibutamoren) is a non-peptide, orally active growth hormone secretagogue that targets ghrelin receptors to elevate GH and IGF-1 levels in preclinical models. PX1 Research provides high-purity research compounds backed by USA synthesis, lot-specific HPLC/MS and endotoxin testing, and same-day dispatch from CA and AZ facilities.
MK-677 (Ibutamoren) is a non-peptide, orally active growth hormone secretagogue that targets ghrelin receptors to elevate GH and IGF-1 levels in preclinical models. PX1 Research provides high-purity research compounds backed by USA synthesis, lot-specific HPLC/MS and endotoxin testing, and same-day dispatch from CA and AZ facilities.
MK-677, also known as Ibutamoren mesylate, is an orally active, non-peptide growth hormone secretagogue that selectively binds to the growth hormone secretagogue receptor 1a (GHSR-1a). In preclinical research models, it demonstrates the ability to stimulate the pulsatile release of endogenous growth hormone (GH) without causing significant disturbances in baseline cortisol or prolactin levels.
Primary laboratory investigations focus on MK-677 for its sustained elevation of serum insulin-like growth factor 1 (IGF-1) and GH over extended 24-hour testing periods. Unlike traditional injectable peptide secretagogues, its non-peptide chemical structure confers high oral bioavailability and a prolonged terminal half-life in animal models.
When evaluating MK-677 for in vitro or animal studies, research facilities mandate strict analytical controls including high-performance liquid chromatography (HPLC) mass confirmation, structural identity verification via mass spectrometry (MS), and low endotoxin thresholds.
MK-677 is a synthetic, non-peptidic spiroindoline compound developed to mimic the endogenous peptide ghrelin. Although often grouped alongside research peptides due to its functional activity on the endocrine axis, MK-677 is structurally distinct from amino acid chains. Its chemical formula is C27H36N4O5S, typically stabilized as a mesylate salt for analytical consistency.
In basic bio-chemical classification, MK-677 functions as a selective agonist of the ghrelin receptor. Endogenous ghrelin plays an integral role in regulating metabolic energy balance, central appetite pathways, and anterior pituitary signaling. By binding directly to these ghrelin receptors in cerebral and pituitary tissues, MK-677 bypasses the requirement for intravenous or subcutaneous delivery, rendering it a uniquely flexible tool in metabolic and endocrine research protocols.
Principal researchers examine MK-677 research literature to analyze how non-peptide small molecules interact with G-protein coupled receptors (GPCRs) to elicit long-acting biological cascades. Its stability in aqueous solution and high biological half-life differentiate it from short-acting peptides that require frequent re-administration in experimental paradigms.
The primary mechanism of action of MK-677 involves the activation of the GHSR-1a receptor located on somatotroph cells in the anterior pituitary gland and across specific hypothalamic nuclei. Receptor binding initiates an intracellular signal transduction cascade mediated by phospholipase C (PLC) and inositol trisphosphate (IP3), triggering intracellular calcium influx and subsequent exocytosis of growth hormone storage vesicles.
Preclinical studies show that this activation amplifies natural pulsatile GH secretion while maintaining the natural physiological feedback architecture. Unlike exogenous GH administration—which suppresses endogenous pituitary output—MK-677 preserves the hypothalamic-pituitary axis's responsiveness to somatostatin (growth hormone-inhibiting hormone), thereby preserving native endocrine regulatory limits.
Follow-on signaling downstream of GH release triggers hepatic transcription and secretion of IGF-1. In rodent models, continuous administration of MK-677 results in a sustained, dose-dependent rise in circulating IGF-1 levels. Furthermore, because it selectively targets the GHSR-1a receptor, preclinical data indicate minimal affinity for adrenocorticotropic hormone (ACTH) or thyroid-stimulating hormone (TSH) pathways under standard experimental parameters.
In research settings, MK-677 is frequently compared against classic growth hormone-releasing peptides (GHRPs) and growth hormone-releasing hormone (GHRH) analogs. While peptides like Ipamorelin and GHRP-6 activate similar anterior pituitary signaling cascades, their structural composition necessitates parental administration and yields a sharp, short-lived GH spike lasting 30 to 120 minutes.
Conversely, MK-677 exhibits an estimated elimination half-life of 24 hours in preclinical subjects. A single administration yields prolonged, multi-phasic GH elevation over an extended period. This long duration of action makes it a valuable model compound for studying long-term anabolic signaling, nitrogen retention, and tissue turnover without introducing handling stress associated with repeated injections.
Another distinct feature is receptor cross-reactivity. First-generation hexapeptides such as GHRP-6 activate ghrelin receptors but often display secondary activity on cortisol and prolactin release at higher concentrations. In contrast, MK-677 demonstrates higher receptor selectivity, minimizing unmapped hormonal confounding factors in complex metabolic assays. Researchers seeking broader secretagogue options can explore the complete PX1 Research catalog for complementary experimental compounds.
Preclinical investigations utilizing MK-677 span multiple biological domains, primarily centering on endocrine signaling, tissue nitrogen balance, bone mineral density, and sarcopenic muscle wasting models. Key experimental paradigms include:
1. Nitrogen Balance and Protein Turnover: In rodent models subjected to dietary restriction or catabolic stress, MK-677 has been demonstrated to reverse diet-induced nitrogen loss, preserving lean tissue mass and accelerating cellular repair markers.
2. Musculoskeletal and Bone Density Models: Animal models of osteopenia and skeletal degradation demonstrate increased bone turnover markers, osteoblast activity, and elevated serum osteocalcin following extended MK-677 exposure.
3. Metabolic and Somatopause Research: Aged animal models exhibit declining endogenous GH and IGF-1 production. Researchers utilize MK-677 to investigate whether selective GHSR-1a re-activation can restore youthful endocrine profiles and mitigate age-related body composition changes.
4. Neuroendocrine Pathways: Studies evaluating central ghrelin receptor activation utilize MK-677 to map hunger signaling, sleep architecture alterations, and neuroprotective cascades in rodent brain tissue.
To maintain consistency across longitudinal protocols, research facilities frequently specify standardized oral formats like MK-677 12.5mg capsules to ensure precise, reproducible dosing in non-clinical assay designs.
In vitro and animal study reproducibility depends entirely on raw compound purity and freedom from synthetic precursors or heavy metal contamination. Laboratory standards for MK-677 require comprehensive analytical validation before sample integration into research workflows.
Purity is assessed using High-Performance Liquid Chromatography (HPLC) equipped with ultraviolet detection (typically set between 210 nm and 254 nm). High-grade research MK-677 must yield a single sharp chromatographic peak corresponding to ≥98.0% purity, with total related impurities remaining under strict threshold limits.
Structural identity is confirmed via Electrospray Ionization Mass Spectrometry (ESI-MS), matching the observed molecular weight against theoretical calculations for the parent compound and its mesylate salt. Additionally, endotoxin testing using the Limulus Amebocyte Lysate (LAL) assay ensures bacterial endotoxins remain below safe analytical thresholds (<0.05 EU/mg), preventing confounding inflammatory responses in cell culture or animal assays.
Selecting a qualified research vendor requires systematic verification of quality control systems, transparency, and supply chain integrity. When auditing suppliers for MK-677 and related research materials, verify the following structured criteria:
Purity Verification: Vendor must provide lot-specific HPLC chromatograms demonstrating ≥98% purity, performed by an accredited independent third-party laboratory rather than internal, unverified testing.
Structural Identification: Mass spectrometry (MS) report matching precise molecular mass must accompany every analytical lot to rule out structural isomers or degraded compounds.
Endotoxin Quantification: Quantitative LAL assay reports proving sub-threshold endotoxin levels must be accessible prior to purchase to safeguard cell culture and animal safety.
Sourcing and Synthesis: Direct domestic sourcing with transparent synthesis logs ensures consistent physical parameters, crystal structures, and dissolution kinetics across batches.
Fulfillment Infrastructure: Same-day processing and temperature-controlled storage prevent thermal degradation during storage and transit.
Technical Documentation: Full safety data sheets (SDS), certificates of analysis (COAs), and batch traceability must be publicly accessible on the vendor's platform.
The scientific validity of experimental data can be severely compromised by substandard or mislabeled research chemicals. Researchers should exercise extreme caution and avoid vendors exhibiting any of the following operational red flags:
Generic or Template COAs: Suppliers that present identical, non-lot-specific analytical certificates across multiple batches without visible raw chromatographic data or mass spectra are masking batch-to-batch variation.
Medical or Consumer Claims: Any vendor promoting research compounds for human consumption, athletic performance enhancement, or body composition therapies violates regulatory boundaries and indicates non-compliant manufacturing practices.
Opaque Sourcing and Overseas Drop-Shipping: Vendors operating without verifiable domestic warehouse locations frequently issue re-labeled imported material that lacks rigorous quality inspection and lot traceability.
Unusually Low Market Pricing: Abnormally low costs often indicate crude chemical synthesis, unremoved intermediate reagents, or heavy metal contamination that distorts experimental outcomes.
For comprehensive literature on vetting chemical suppliers and understanding analytical standards, consult the PX1 Research knowledge base.
PX1 Research provides institutional laboratories and independent researchers with reference-grade MK-677 synthesized under strict quality controls. Every production batch undergoes rigorous third-party testing to guarantee structural identity, high chromatographic purity (≥98%), and minimal endotoxin levels.
When you order MK-677 12.5mg capsules or alternative reference standards from PX1 Research, your order is dispatched directly from our state-of-the-art facilities in California and Arizona. Orders placed before 3:00 PM EST (Monday–Friday) ship the same day via tracked domestic transit, ensuring thermal stability and minimal transit times.
Every shipment includes direct access to lot-specific Certificate of Analysis documentation downloadable via QR code or direct portal access. Our technical support team consists of experienced research specialists ready to answer analytical, solubility, or storage questions. Visit our catalog to review live availability or contact our team for wholesale and bulk research inquiries.
What is MK-677 in scientific terms?
MK-677 (Ibutamoren mesylate) is a non-peptide, orally active growth hormone secretagogue. It functions as a selective agonist of the growth hormone secretagogue receptor 1a (GHSR-1a), mimicking the action of endogenous ghrelin to stimulate growth hormone and IGF-1 release in preclinical models.
Is MK-677 a peptide or a SARMs compound?
MK-677 is neither a peptide nor a Selective Androgen Receptor Modulator (SARM). Chemically, it is a small-molecule spiroindoline. While often categorized alongside peptides or SARMs in research discussions due to its oral bioavailability and anabolic signaling research, it operates strictly via ghrelin receptor pathways without binding to androgen receptors.
How does MK-677 elevate growth hormone and IGF-1?
MK-677 selectively binds to GHSR-1a receptors on anterior pituitary somatotrophs and hypothalamic neurons. This binding triggers intracellular calcium signaling, causing pulsatile secretion of endogenous growth hormone. Downstream GH signaling in the liver subsequently increases systemic production of insulin-like growth factor 1 (IGF-1).
How long does MK-677 remain active in research models?
Preclinical pharmacokinetic models indicate that MK-677 has an elimination half-life of approximately 24 hours. A single administration produces sustained elevations in circulating growth hormone and IGF-1 levels throughout a 24-hour cycle, unlike short-acting peptide secretagogues.
What purity level should laboratories specify for MK-677?
Laboratories should specify MK-677 with a verified purity of ≥98.0% as determined by high-performance liquid chromatography (HPLC). Mass spectrometry (MS) mass verification and low endotoxin levels (<0.05 EU/mg) are also required to avoid experimental artifacts in vitro or in vivo.
Do you provide a Certificate of Analysis (COA) for every MK-677 lot?
Yes. PX1 Research provides downloadable, lot-specific Certificates of Analysis for every batch of MK-677. COAs contain full analytical data, including HPLC purity chromatograms, mass spectrometry mass confirmation, and quantitative endotoxin testing results.
How fast does PX1 Research ship MK-677 orders?
PX1 Research dispatches orders placed Monday through Friday before 3:00 PM EST on the same day. All shipments originate from our domestic California or Arizona fulfillment centers with fully tracked expedited shipping.
Is MK-677 legal to purchase for laboratory research in the US?
Yes. MK-677 is legal to purchase across the United States as a research chemical intended strictly for in vitro and laboratory preclinical research. It is not approved for human consumption, therapeutic treatment, or clinical use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.